Skip to main content

Table 3 Primers used in this study

From: Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system

Primers

Sequences

delpal-1

TGTGATAATAATTAATTGAATAGTAAAGGAATCATTGAAGCCGATCATATTCAATAACC

delpal-2

CAATAGTTGATGTCTGAAGTTACTGCTCATGCAATTCTCAAGCTTATCGATACCGTCGA

C-pal-1

GATCCGTGCTGAATTTGGTT

C-pal-2

AAGTTGAGTGACGCGGTCTT

ompASCspA-1

GGGTGGCATGGTATGGCGTGCAGACACTAAATCCAACGTTGGCGGCGGCGGCAGCGGCGC

ompASCspA-2

AAAACCCCGCAGCAGCGGGGTTTTTCTACCAGACGAGAACTGTAGGCTGGAGCTGCTTCGA

C-ompA-1

GTTTCCGCGATTCTCTTCTG

C-ompA-2

TAATGCGGAACACCAGCATA